Hypertension as cardiovascular risk factor in chronic kidney disease
M Burnier, A Damianaki - Circulation research, 2023 - Am Heart Assoc
Hypertension is the leading modifiable cause of premature death and hence one of the
global targets of World Health Organization for prevention. Hypertension also affects the …
global targets of World Health Organization for prevention. Hypertension also affects the …
Measurement of blood pressure in humans: a scientific statement from the American Heart Association
The accurate measurement of blood pressure (BP) is essential for the diagnosis and
management of hypertension. This article provides an updated American Heart Association …
management of hypertension. This article provides an updated American Heart Association …
[HTML][HTML] 2022 Guidelines of the Taiwan Society of Cardiology and the Taiwan Hypertension Society for the management of hypertension
Hypertension is the most important modifiable cause of cardiovascular (CV) disease and all-
cause mortality worldwide. Despite the positive correlations between blood pressure (BP) …
cause mortality worldwide. Despite the positive correlations between blood pressure (BP) …
Hypertension in dialysis patients: a consensus document by the European Renal and Cardiovascular Medicine (EURECA-m) working group of the European Renal …
PA Sarafidis, A Persu, R Agarwal… - Nephrology dialysis …, 2017 - academic.oup.com
In patients with end-stage renal disease (ESRD) treated with haemodialysis or peritoneal
dialysis, hypertension is common and often poorly controlled. Blood pressure (BP) …
dialysis, hypertension is common and often poorly controlled. Blood pressure (BP) …
Masked hypertension and elevated nighttime blood pressure in CKD: prevalence and association with target organ damage
PE Drawz, AB Alper, AH Anderson… - Clinical Journal of the …, 2016 - journals.lww.com
Results The percentages of participants with controlled BP, white-coat, masked, and
sustained hypertension were 49.3%, 4.1%, 27.8%, and 18.8%, respectively. Compared with …
sustained hypertension were 49.3%, 4.1%, 27.8%, and 18.8%, respectively. Compared with …
[HTML][HTML] 2015 guidelines of the Taiwan Society of Cardiology and the Taiwan Hypertension Society for the management of hypertension
It has been almost 5 years since the publication of the 2010 hypertension guidelines of the
Taiwan Society of Cardiology (TSOC). There is new evidence regarding the management of …
Taiwan Society of Cardiology (TSOC). There is new evidence regarding the management of …
Prevalence of white-coat and masked hypertension in national and international registries
M Gorostidi, E Vinyoles, JR Banegas… - Hypertension …, 2015 - nature.com
In the past two decades, techniques for the measurement of blood pressure outside the
medical setting have unmasked highly prevalent situations. A significant proportion of …
medical setting have unmasked highly prevalent situations. A significant proportion of …
Unmasking masked hypertension: prevalence, clinical implications, diagnosis, correlates and future directions
Abstract 'Masked hypertension'is defined as having non-elevated clinic blood pressure (BP)
with elevated out-of-clinic average BP, typically determined by ambulatory BP monitoring …
with elevated out-of-clinic average BP, typically determined by ambulatory BP monitoring …
Blood pressure variability increases with advancing chronic kidney disease stage: a cross-sectional analysis of 16 546 hypertensive patients
PA Sarafidis, LM Ruilope, C Loutradis… - Journal of …, 2018 - journals.lww.com
Objective: Increased BP-variability predicts cardiovascular morbidity and mortality in
hypertensives. This study aimed to examine short-term BP-variability according to renal …
hypertensives. This study aimed to examine short-term BP-variability according to renal …
Assessment of achieved clinic and ambulatory blood pressure recordings and outcomes during treatment in hypertensive patients with CKD: a multicenter prospective …
Background We investigated the effect of having clinic and/or ambulatory blood pressures
(BPs) not at goal on cardiorenal risk in patients with non− dialysis-dependent chronic kidney …
(BPs) not at goal on cardiorenal risk in patients with non− dialysis-dependent chronic kidney …